Your browser doesn't support javascript.
loading
A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia.
Hsu, Cherng-Ru; Chen, Yi-Hsun; Liu, Chih-Peng; Chen, Chih-Hung; Huang, Kuo-Kuei; Huang, Jui-Wen; Lin, Meng-Nan; Lin, Chih-Lung; Chen, Wan-Ru; Hsu, Yi-Ling; Lee, Tze-Chung; Chou, Shuen-Hsiang; Tu, Chia-Mu; Hwang, Chrong-Shiong; Huang, Yu Chuan; Lu, Da-Wen.
Afiliação
  • Hsu CR; Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China.
  • Chen YH; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Liu CP; Institute of Nanoengineering and Microsystems, National Tsing Hua University, Hsinchu, Republic of China.
  • Chen CH; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Huang KK; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Huang JW; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Lin MN; Institue of Biotechnology, National Tsing Hua University, Hsinchu, Republic of China.
  • Lin CL; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Chen WR; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Hsu YL; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Lee TC; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Chou SH; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Tu CM; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Hwang CS; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Huang YC; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
  • Lu DW; Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China.
Invest Ophthalmol Vis Sci ; 60(2): 624-633, 2019 02 01.
Article em En | MEDLINE | ID: mdl-30735565
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glaucoma / Inibidores de Proteínas Quinases / Quinases Associadas a rho / Hiperemia / Pressão Intraocular / Anti-Hipertensivos Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glaucoma / Inibidores de Proteínas Quinases / Quinases Associadas a rho / Hiperemia / Pressão Intraocular / Anti-Hipertensivos Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China